TRACON Pharmaceuticals Inc (NASDAQ:TCON)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TCON

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TCON

  • Market Cap$146.310m
  • SymbolNASDAQ:TCON
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS89237H2094

Company Profile

TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway.TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.

Latest TCON news

Currently there for this company. Visit our news hub for other news .